We established an ideal prognostic cut-off value of 264.4 ng/mL for preoperative osteopontin serum levels above which CRLM patients showed a strikingly reduced median overall survival of only 304 days after tumour resection compared to 1394 days for patients with serum levels below this cut-off value. The gene discussed is SPP1; the disease is neoplasm.